BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24803819)

  • 1. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.
    Chang MC; Chen CH; Liang JD; Tien YW; Hsu C; Wong JM; Chang YT
    World J Gastroenterol; 2014 May; 20(17):5060-5. PubMed ID: 24803819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
    Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
    Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hepatitis B virus and pancreatic cancer.
    Hassan MM; Li D; El-Deeb AS; Wolff RA; Bondy ML; Davila M; Abbruzzese JL
    J Clin Oncol; 2008 Oct; 26(28):4557-62. PubMed ID: 18824707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Previous hepatitis B viral infection-an underestimated cause of pancreatic cancer.
    Batskikh S; Morozov S; Dorofeev A; Borunova Z; Kostyushev D; Brezgin S; Kostyusheva A; Chulanov V
    World J Gastroenterol; 2022 Sep; 28(33):4812-4822. PubMed ID: 36156926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
    Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
    Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatorial prevalence of hepatitis B and C markers in patients with human immunodeficiency virus infection in a general hospital].
    Tovo CV; Dos Santos DE; de Mattos AZ; de Almeida PR; de Mattos AA; Santos BR
    Arq Gastroenterol; 2006; 43(2):73-6. PubMed ID: 17119657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.
    Drosten C; Nippraschk T; Manegold C; Meisel H; Brixner V; Roth WK; Apedjinou A; Günther S
    J Clin Virol; 2004 Jan; 29(1):59-68. PubMed ID: 14675872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of hepatitis B and C viral infections in Ladakh region.
    Khan MA; Zargar SA; Upadhyay J; Lone TA; Aggarwal R; Bashir G; Ali M; Rabyang S; Namgyal T; Wani ZA
    Indian J Gastroenterol; 2018 Nov; 37(6):504-510. PubMed ID: 30543047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south Brazilian region: metropolitan area of Florianópolis, Santa Catarina.
    Voigt AR; Strazer Neto M; Spada C; Treitinger A
    Braz J Infect Dis; 2010; 14(1):60-5. PubMed ID: 20428656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
    Pinto FP; Ferreira OC; Olmedo DB; Precioso PM; Barquette FR; Castilho MC; Silva SG; Pôrto LC
    Ann Hepatol; 2015; 14(6):815-25. PubMed ID: 26436353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
    Su YC; Lin PC; Yu HC; Wu CC
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
    Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
    Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
    de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
    Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C in a Brazilian deaf community.
    Pacher BM; Costa MR; Nascimento MM; Moura MC; Passos AD
    Rev Soc Bras Med Trop; 2015; 48(5):603-6. PubMed ID: 26516972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.